Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | +3.50% | +13.21% | -0.27% |
09/05 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
09/05 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.27% | 222M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.49% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio : B. Riley Raises INmune Bio's PT to $34 from $29 Driven by Pipeine Progress, Simplification of Capital Structure; Keeps Buy Rating